CRON.TO
Cronos Group Inc
Price:  
4.05 
CAD
Volume:  
70,866.00
Canada | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CRON.TO EV/EBITDA

-39.2%
Upside

As of 2025-12-22, the EV/EBITDA ratio of Cronos Group Inc (CRON.TO) is -26.72. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CRON.TO's latest enterprise value is 468.47 mil CAD. CRON.TO's TTM EBITDA according to its financial statements is -17.53 mil CAD. Dividing these 2 quantities gives us the above CRON.TO EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 4.3x - 7.2x 5.6x
Forward P/E multiples 4.7x - 7.7x 6.0x
Fair Price 2.53 - 2.37 2.46
Upside -37.5% - -41.5% -39.2%
4.05 CAD
Stock Price
2.46 CAD
Fair Price

CRON.TO EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-12-19 -19.36
2025-12-18 -19.84
2025-12-17 -21.42
2025-12-16 -24.59
2025-12-15 -21.58
2025-12-12 -26.33
2025-12-11 -17.15
2025-12-10 -16.67
2025-12-09 -13.82
2025-12-08 -9.71
2025-12-05 -10.03
2025-12-04 -10.50
2025-12-03 -10.66
2025-12-02 -9.55
2025-12-01 -10.66
2025-11-28 -9.55
2025-11-27 -10.34
2025-11-26 -10.34
2025-11-25 -10.03
2025-11-24 -9.87
2025-11-21 -8.28
2025-11-20 -6.86
2025-11-19 -7.97
2025-11-18 -9.55
2025-11-17 -9.08
2025-11-14 -9.87
2025-11-13 -10.50
2025-11-12 -11.61
2025-11-11 -10.82
2025-11-10 -11.92
2025-11-07 -10.18
2025-11-06 -10.18
2025-11-05 -10.18
2025-11-04 -10.18
2025-11-03 -11.13
2025-10-31 -11.13
2025-10-30 -9.23
2025-10-29 -9.55
2025-10-28 -10.34
2025-10-27 -10.03
2025-10-24 -11.29
2025-10-23 -10.03
2025-10-22 -8.44
2025-10-21 -10.66
2025-10-20 -11.13
2025-10-17 -10.66
2025-10-16 -10.18
2025-10-15 -12.72
2025-10-14 -11.61
2025-10-10 -10.98